In fact, methylation of the CDKN2A promoter CpG island has been observed in the sputum of subjects at risk for lung cancer 3 years prior to diagnosis [18] and in the sputum of asymptomatic heavy smokers [19]. Here, CDKN2A is linked to lung carcinoma.